chrisvoncsefalvay/vaers-outcomes huggingface dataset:
MEMBER RECEIVED ANTHRAX#1 AND SMALLPOX VACCINE ON 11 JULY 2003 (HAD BEEN PREVIOUSLY VACCINATED AS A CHILD AGAINST SMALLPOX).  ON 15 JULY DEVELOPED SUBJECTIVE FEVERS/SLIGHT HEADACHE/MALAISE WITH A DIFFUSE FLAT, MACULO-PAPULAR RASH INVOLVING HIS ENTIRE TRUNK AND PORTIONS OF HIS EXTREMITIES.  THERE WAS NO OTHER MUCOUS MEMBRANE INVOLVEMENT (SPECIFICALLY OROPHARYNX/EYES).  DENIED BLURRED VISION/STIFF NECK/N/V/D/CP/SOB/PALPS/ABD PAIN/NEURO COMPLAINTS.  PICTURES OF THIS RASH WERE FORWARDED BY ME HOSPITAL.  THEY WERE SHOWN TO AN ALLERGIST AND THERE WAS CONCERN THAT THIS RASH MAY IN FACT, BE ERYTHEMA MULTIFORME (I NOTED ABSOLUTELY NO TARGET LESIONS AND THERE WAS NO MUCOUS MEMBRANE INVOLVEMENT).  THEY REQUESTED THAT THE MEMBER HAVE THE FOLLOWING LAB TESTS DRAWN: CRP, CBC, ESR, C3, C4, CH50, C1Q BINDING, RAJI CELLS.  THESE WERE DRAWN TODAY AND SENT TO MEDICAL CLINIC HERE.  OF NOTE, RASH HAS IMPROVED SIGNIFICANTLY SINCE YESTERDAY ALTHOUGH MEMBER IS STILL C/O SLIGHT HEADACHE.  HOWEVER, HE IS NONTOXIC AND HAS NO MENINGISMUS OR APPRECIABLE ADENOPATHY AT THIS TIME.
Patients face became itchy and red. Patient was treated with 25mg oral Benadryl and symptoms resolved within 1 hour
I have had headaches everyday since having the vaccine. I have been treating it with Tylenol as instructed by store.
Everything was mild (low grade fatigue, minor injection site soreness and itchyness) until 1AMish. I startes feeling achey and had chills which made it hard to sleep.  My joints, hips, and knees hurt a lot. 400mg of ibuprofen helped me enough to sleep.  I woke around 8am. Significant muscle aches ans joint pain. Ate breakfast at too ibuprofen at 9:30am.  It didnt help much, I managed to hobble to the grocery store for food late morning.  11:30 am my appetite was low, muscle aches bad. I cant recall if I took ibuprofen. Fatigue soon set in and I slept for a few hours.  Around 630pm,  my chills are back. I feel warm but am afebrile. My body temp is higher than normal (97.8 vs 96.6).    My muscles and joints hurt a lot. I might be getting a headache. I have no appetite. My face feels hot but my body is freezing. All day I have brief bouts of nausea that are mild and fleeting. I only gagges once when a sharp wave hit.
MODERNA COVID #3 VACCINE GIVEN 10/25/21,LOT # 011F21A; pt had a positive COVID test on 2/17/22 from Fast Pace Clinic in Lafayette, TN; 2/24/22 pt to ED with increasing SOB and productive cough; admitted; hypoxic; BiPAP; dexamethasone and ABX given; COVID pneumonia with ARDS; pt had a sudden cardiopulmonary arrest; ACLS protocol given; return of pulse 5 times; continued to have cardiopulmonary arrest; family decided to discontinue CPR and pt expired in the hospital
Covid-19 positive; loss of sense of smell; loss of sense of taste; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of ANOSMIA (loss of sense of smell), AGEUSIA (loss of sense of taste) and SARS-COV-2 TEST POSITIVE (Covid-19 positive) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 from 17-Jan-2021 to 25-Jan-2021.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced ANOSMIA (loss of sense of smell) and AGEUSIA (loss of sense of taste). On 17-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Covid-19 positive). On 23-Jan-2021, ANOSMIA (loss of sense of smell) and AGEUSIA (loss of sense of taste) had resolved. On 25-Jan-2021, SARS-COV-2 TEST POSITIVE (Covid-19 positive) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Information has been received from a medical assistant concerning a 40 year old female patient with an allergy to amoxicillin and a history of pneumonia who on 11/15/01 was vaccinated with a dose of pneumococcal vaccine 23 polyvent (lot # 640577/0995L). The medical assistant reported that there was a small area of psoriasis near the injection site prior to the administration of the vaccine. Within a few hours post vaccination, the patient was seen and treated in the ER for swelling, redness, and cellulitits of the left arm from the injection site to below the elbow. The area was warm to the touch. The patient was treated with diphehydramine (BENADRYL) and ibuprofen. On 11/18/2001 the patient recovered. No additional information is expected.
This spontaneous report was received from a physician refers to an approximately 50 year old male patient. The patient was vaccinated with a dose of PNEUMOVAX 23. On an unknown date, the patient experienced high fever of 104 degrees, aches and pain, dizziness and excruciating pain in the armpit area after receiving the vaccination. There were no treatment information reported. The outcome of the events were unknown at the time of this report. This is one of the several reports received by the same reporter. Additional information has been requested.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38-year-old female patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 38 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). Concomitant medication(s) included: MONTELUKAST. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Anti-viral details stated product used for COVID 19 Treatment was Paxlovid and Treatment was start from 17May2022. Adverse events start date was 17May2022.The patient has not recovered. Experienced strong metallic taste in mouth about an hour after taking first dose. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
I contracted an Influenza.  I do not know which variety of influenza. It was not related to COVID 19 or the vaccine.  I had an extreme cough and sore throat.  I tested negative for COVID 19 three times.
Library staff being skin tested as contacts to homeless PPD placed on 03/29/2004, patient related within an hours the lower arm became stiff and burning and the tips of the three middle fingers became numb on the arm of the injection site. Called private physician and told it was probably a local reaction. On 3/31 when being read everything had resolved but
Bloody stool, mother took child to hospital where she was told it was an adverse reaction to ROTARIX.
Information has been received from a caller concerning her 12 month daughter with food allergies and no pertinent medical history, on 03-JUL-2007 was given her first dose of PEDVAXHIB, who on 01-MAY-2008 was vaccinated with VARIVAX (Merck) (caller did not know if it was VARIVAX (Merck) or not). The caller stated that after her daughter was vaccinated with VARIVAX (Merck) her daughter developed low grade fever and a rash that started on her leg and moved over her body. On 27-AUG-2008, the patient was given her second dose of PEDVAXHIB. The patient sought unspecified medical attention, no lab diagnostics studies performed. Additional information has been requested.
For past 24hours- Low grade fever has remained between 100.1 and 99.3.  Muscle Aches Headache
Went to go get a Covid test and it came back positive; Went to go get a Covid test and it came back positive; had a bitter taste in her mouth; This is a spontaneous report from a Pfizer-sponsored program. A contactable Nurse(patient) reported that a female patient of an unspecified age received first dose BNT162B2 (Pfizer BioNTech Covid 19 vaccine), via an unspecified route of administration on 02Jan2021 at single dose for COVID-19 immunization.  The patient medical history was none. The concomitant medications were none. The patient got the vaccine on the 02Jan2021. After getting the vaccine she started losing taste. After getting vaccine in Jan2021 she had a bitter taste in her mouth. She went to go get a Covid test and it came back positive in Jan2021 and she had additional questions. The patient stated it was the Pfizer vaccine but she did not think it gave her the Covid because she had symptoms before that period then they just came back. If it feels with adverse reaction or anything just wanted to know if it was associated with the vaccine or not.The patient stated she did not lose taste, she just had a bitter taste. She could taste everything. She just had bitter taste in her mouth. She did not think bitter taste in her mouth was related to product. The patient just find anybody who can explain to her if it was okay for her to go for the second dose because there was no more information about the Pfizer because she had Covid. She just needed to know it was ok for her to get the second dose or stop the vaccine. The patient was informed to contact Medical information. The outcome of the events was unknown.  Information on the batch number/lot number has been requested.; Sender's Comments: Based on the available information and time association, the possible contribution of suspect BNT162B2 administration to the COVID-19 infection and bitter teste cannot be excluded.
Extreme fatigue, severe neck pain (right side only), nausea. Began at wakeup on 4/7 (6am). The same symptoms and severity lasted all of 4/7, 4/8 and 4/9. On 4/10 (today) I was able to function better but only at 50% of normal rate.   Pushed lots of water and slept 18-20 hours 4/7 & 4/8
rash all over the body; This is a spontaneous report from a contactable pharmacist. A 55-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on an unspecified date as a dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Reporter stated that, reporter had a patient about to get her second vaccine, Covid vaccine (not confirmed that it was the Pfizer BioNTech Covid-19 vaccine). Patient developed rash all over the body after the 1st dose of vaccine (not confirmed that it was the Pfizer BioNTech Covid-19 vaccine). She still has the rash from her last dose 3 weeks ago. Patient informed the pharmacist stating, it (rash) came a couple of hours after she got the shot and then by 24 hours she had a full body rash. The patient was ready to get 2nd dose of vaccine. The reporter inquired if this patient is able to get 2nd dose. Reporter queried stating, if the patient does get shot, can she pre-medicate or post medicate with Benadryl. The event was non-serious. The clinical outcome for the event was not recovered.  Follow-up attempts are completed. No further information is expected.
Patient fainted in waiting area. Came to in less than a minute. Father and brother were present.  Patient  was extremely pale. he was given an ice pack because he fell against the wall/door. He was also given water.
Information has been received from a physician concerning a patient who was vaccinated with GARDASIL.  The physician reported that a patient experienced on 01-AUG-2008 after having at some point previously received a GARDASIL injection.  Upon internal review seizure was considered an other important medical event.  Additional information has been requested. 8/22/08 Reviewed PCP office records which included ER contact info, labs & vax records. FINAL DX: vasovagal syncope; possible idiopathic seizure Records reveal patient immediately after 1st HPV injection 2/13/08 felt dizzy fainted & had tremors lasting less than 30 second, awoke alert but tired.  Recovered completely & d/c to home.  Parent informed MD of fainting & tremors while vacationing out of state, woke up confused & had HA x 2 days.  Seen in ER where CT scan & labs were WNL.  8/26/08 Reviewed ER medical records of 8/1/2008. FINAL DX: syncopal episode, probable vasovagal  Records reveal patient experienced trip & fall into a few inches of water at beach.  Got up & walked a few steps then fell forward & had seizure lasting 10-20 sec.  Patient had no memory of event.   Had HA & sore neck in ER.
Pt developed outbreak of herpes Zoster approximately 36 hours after receiving the 2nd Moderna vaccine. Location- R LE.
Information has been received from a pharmacy student concerning a female patient who on 11-JUN-2007 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). On 18-JUN-2007, the patient experienced dizziness, rapid heart rate, weakness, shortness of breath, headache and diarrhea. It was reported that the symptoms resolved in 2 days with no medical treatment. Unspecified medical attention was sought. On 20-JUN-2007, the patient recovered. No product quality complaint was involved. Additional information has been requested.
This spontaneous case reported by a consumer, describes the occurrence of peripheral swelling (arm is swollen), pain in extremity (arm has broken out a little bit), inappropriate schedule of product administration (first dose in November 2020; second dose on June 11, 2021) and rash on the arm in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. Concomitant products included potassium and vitamins (NOS) for an unknown indication. November 2020, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jun 11, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. On an unknown date, patient had peripheral swelling (arm is swollen), pain in extremity (arm has broken out a little bit), inappropriate schedule of product administration (first dose in November 2020; second dose on June 11, 2021) and rash on the arm. At the time of the report, peripheral swelling (arm is swollen), pain in extremity (arm has broken out a little bit) and rash on the arm outcome: unknown; and inappropriate schedule of product administration (first dose in November 2020; second dose on June 11, 2021) resolved. For the swelling on her arm, she used an icepack as a treatment. This case linked to MOD-2021-220945 (patient link).
Extreme night sweats to the point of wrenching bidding. Would occur they the nite waking me. Never had this before.
This spontaneous report was received from a licensed vocational nurse regarding unspecified patients of unknown age and gender. The patients' pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of LIQUID PEDVAXHIB (dose and route were not reported, lot # reported as L014429 with expiration date 15-MAR-2018 or lot #L009649 with expiration date 29-NOV-2017) There were no adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
FEVER, REDDISH COLOR STOOL, DIARRHEA, WITHIN 8 HOURS OF VACCINE.TREATED WITH TYLENOL, FLUIDS.GUAIC NEGATIVE
15 min after vaccine administration, pt experienced frontal headache, diffuse subjective weakness of LE, and gait instability. Admitted to medical center for monitoring  and workup.
Light headed; fatigue; Arm soreness; headache; neck aches; sinus congestion; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727) via unspecified route of administration in the left arm on an unknown date (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included menstrual pain, and unknown skin disorder which was not diagnosed but it was unknown if the skin issues were possibly autoimmune related. The patient did not have any known allergies to medications, food and other products. Concomitant medication included ibuprofen (MANUFACTURER UNKNOWN) for menstrual pain started from an unknown date in Mar2021 (reported as day before vaccination). Prior to vaccination, the patient was not tested positive for COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccine 4 weeks prior to the COVID vaccine. On 25Mar2021 at 08:15, the patient experienced light headed / little dizzy after shot for about 6 hours, fatigue, arm soreness, head and neck aches, especially at base of the skull and some sinus congestion and continuing fatigue the next morning. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcomes of the events arm soreness was recovering at the time of this report. The clinical outcome of the event fatigue was not recovered at the reporting time; while that of the events light headed/little dizzy, headache, neck aches and sinus congestion were unknown.  No follow-up attempts are possible. No further information is expected.
Cognitive disorder, fatigue, Hypersomnia, Hypertension. This case was reported by a healthcare professional and described the occurrence of difficulty responding in a 90-year-old male subject who was vaccinated with influenza vaccine trivalent (FLULAVAL, GlaxoSmithKline) for prophylaxis. Concurrent medical conditions included high blood pressure. Concurrent medications included Unknown (Unknown medication). On September 10 2009 at 10:00 the subject received unspecified dose of FLULAVAL (unknown, left arm). In September 2009, at an unspecified time after vaccination with FLULAVAL and an unspecified time after taking unknown blood pressure medication, the subject experienced difficulty responding, tiredness, sleep more than normal and low blood pressure. The reporter stated "cut blood pressure medication in half. Scheduled for a cardiogram today." At the time of reporting, low blood pressure had resolved. Follow-up received on 18 September 2009, via healthcare professional, reported an additional event of extreme fatigue. The subject was taking NORVASC. At the time of this report fatigue was worse.
I got the shot at 6:00 pm on March 29th. Around 12:30 am (March 30th) (about 6 hours after receiving the Johnson and Johnson COVID) vaccine I woke up with chills, body aches all over and a headache. That along with fatigue continued for about 28 hours. I missed a day of work due to not feeling well. The following day (March 31st) I still felt tired and spacey. My headache was better. But I started having hot flashes and more minor body aches. Not as severe body aches as the previous day. April 1st I felt back to normal. I called my doctor's nurse on March 30th to ask if I could take Tylenol to help with my bad headache. She advised not to so I didn't take any Tylenol or Ibprophen.
Day after injection began redness, swelling and itching of left upper arm from below injection site to above elbow on the outer portion of the arm.
Firm swelling of soft tissues over the R deltoid area  accompanied by marked erythema and itching , onset 8 days post-vaccination.  Worsened over subsequent 2-3 days then gradually improved but still persisting  fairly minimally today with continued mild warmth and erythema - 13 days s/p injection - covering an area approx 7cm x 10cm.  (Some photos available).   Unknown if related but have also  had bilateral serous otitis over this same time frame, with no previous hx of this. Also experiencing muscle aches in both legs posteriorly.
As a user of  the  hormonal birth control, Mirena IUD, I do not have monthly menstruation which has been consistent over the length of 9 years of use of IUD. On 03/09/2022 experienced sudden and heavy vaginal bleeding after 9 years of monthly menstruating not occurring while being prescribed and using Mirena IUD birth control.  Heavy and unusual bleeding accompanied by intense abdominal cramps has not subsided for a period of 5 days.  Bleeding amount and duration is also inconsistent with prior menstrual history without birth control, in which pervious periods where light- 3 to 4 days of bleeding with minimal to no cramps.
Dizziness and nausea immediately on receiving vaccine shot. Blood pressure elevated at 140/85. Dizziness lasted 3 hours after shot
Go shot at 8:30am at home. At 10pm heart was racing and I got very dizzy. Went right to bed woke up about 7am all symptoms gone.
This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after after 4 temperature excursions), PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after after 4 temperature excursions) and NO ADVERSE EVENT (No aderse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 023H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after after 4 temperature excursions), PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after after 4 temperature excursions) and NO ADVERSE EVENT (No aderse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after after 4 temperature excursions), PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after after 4 temperature excursions) and NO ADVERSE EVENT (No aderse event) outcome was unknown.           No concomitant medications were reported.   It was unknown if patient receive any other vaccines in the 4 weeks prior to COVID-19 vaccine.  It was reported that vaccine was moved from freezer to refrigerator on 12/2/22 of the ten vials in question 43 injections were given and 7 doses were wasted. Vaccine administered after after 4 temperature excursions.  No treatment medication was provided.  This case contains information for the 3rd of 43 adult patients described by the reporter.
This case was reported by a nurse and described the occurrence of injection site cellulitis in a 4 year old female patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed (Infanrix).  On 08/17/2004, the patient received the 5 dose of Infanrix in the arm (lot dTPA598A2).  On 08/17/2004, the patient also received injections of measles, mumps and rubella virus vaccine (MMR II, Merck) and poliomyelitis virus vaccine (Ipol, Aventis Pasteur).  Approximately 48 hours after the administration of Infanrix, on 08/19/2004, the patient experienced an injection site reaction at the site of the Infanrix administration.  The patient was seen by a physician, who noted a reaction local to the injection site, but larger and more red and hot than normally seen.  A diagnosis of injection site cellulitis was made.  The patient was prescribed cefprozil (Cefzil).  The event improved on 08/20/2004.  The nurse considered the injection site cellulitis to probably be related to vaccination with Infanrix.
I contracted COVID-19. My symptoms included congestion, a bad throat, and coughing for a few days. I had a high temperature as well. I took a COVID-19 test, but the result was negative. However, the symptoms continue to worsen. I took another COVID-19 test and it was positive. I went to urgent care and I received PAXLOVID.